- Home
- WAVE vs GNTA Comparison
WAVE vs GNTA Comparison
Compare WAVE & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAVE | GNTA |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | Israel | Italy |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3M | 41.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WAVE | GNTA |
|---|---|---|
| Price | $6.17 | $1.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 122.7K |
| Earning Date | 11-12-2025 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $168,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $400.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.41 | $1.28 |
| 52 Week High | $17.38 | $10.00 |
Technical Indicators
Market Signals| Indicator | WAVE | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 36.11 |
| Support Level | $6.39 | $1.28 |
| Resistance Level | $7.00 | $1.77 |
| Average True Range (ATR) | 0.28 | 0.18 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 16.22 | 21.74 |
Price Performance
Historical ComparisonAbout WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.